Sbi Securities Co., Ltd. Milestone Pharmaceuticals Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 6 shares of MIST stock, worth $11. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 4
50.0%
Holding current value
$11
Previous $3,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
54Shares Held
18.6MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.89 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.64 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.99 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.57 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.78 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $59.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...